ALC – Alcon Inc.
ALC — Price & Forward EBITDA
Forward EBITDA (M)
Float Short %
1
Margin Of Safety %
8
Put/Call OI Ratio
1.41
EPS Next Q Diff
-0.29
EPS Last/This Y
0.37
EPS This/Next Y
-0.64
Price
74.68
Target Price
96.9
Analyst Recom
1.65
Performance Q
-7.41
Upside
-42.0%
Beta
1.02
Ticker: ALC
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-03-09 | ALC | 81.87 | 1.80 | 0.26 | 13833 |
| 2026-03-10 | ALC | 80.68 | 1.79 | 44.00 | 13914 |
| 2026-03-11 | ALC | 80.77 | 1.79 | 0.47 | 13895 |
| 2026-03-12 | ALC | 78.51 | 1.77 | 0.78 | 14045 |
| 2026-03-13 | ALC | 78.5 | 1.77 | 0.78 | 14045 |
| 2026-03-17 | ALC | 77.78 | 1.71 | 0.28 | 14666 |
| 2026-03-18 | ALC | 75.75 | 1.70 | 0.89 | 14724 |
| 2026-03-19 | ALC | 75.01 | 1.66 | 0.81 | 14747 |
| 2026-03-20 | ALC | 73.63 | 1.59 | 8.00 | 14478 |
| 2026-03-23 | ALC | 74.14 | 1.51 | 2.29 | 10251 |
| 2026-03-24 | ALC | 74.23 | 1.50 | 0.19 | 10233 |
| 2026-03-25 | ALC | 75.23 | 1.46 | 1.94 | 10361 |
| 2026-03-26 | ALC | 74.45 | 1.46 | 0.18 | 10394 |
| 2026-03-27 | ALC | 73.33 | 1.44 | 1.38 | 10446 |
| 2026-03-30 | ALC | 73.68 | 1.44 | 0.33 | 10442 |
| 2026-03-31 | ALC | 75.38 | 1.39 | 2.00 | 10665 |
| 2026-04-01 | ALC | 75.53 | 1.39 | 2.84 | 10742 |
| 2026-04-02 | ALC | 74.61 | 1.41 | 1.59 | 10839 |
| 2026-04-06 | ALC | 74.65 | 1.41 | 1.20 | 10938 |
| 2026-04-07 | ALC | 74.69 | 1.41 | 0.71 | 10944 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-03-09 | ALC | 81.85 | 12.4 | 129.0 | 3.44 |
| 2026-03-10 | ALC | 80.65 | 12.4 | 111.2 | 3.44 |
| 2026-03-11 | ALC | 80.77 | 12.4 | 106.0 | 3.44 |
| 2026-03-12 | ALC | 78.45 | 13.2 | 78.0 | 3.44 |
| 2026-03-13 | ALC | 77.32 | 13.2 | 79.8 | 3.44 |
| 2026-03-17 | ALC | 77.80 | 13.2 | 99.3 | 3.44 |
| 2026-03-18 | ALC | 75.75 | 13.2 | 63.8 | 3.44 |
| 2026-03-19 | ALC | 75.00 | 13.2 | 82.4 | 3.44 |
| 2026-03-20 | ALC | 73.66 | 13.2 | 68.4 | 3.44 |
| 2026-03-23 | ALC | 74.14 | 13.2 | 107.5 | 3.44 |
| 2026-03-24 | ALC | 74.24 | 13.2 | 108.6 | 3.44 |
| 2026-03-25 | ALC | 75.26 | 13.2 | 120.0 | 3.44 |
| 2026-03-26 | ALC | 74.47 | 13.2 | 88.1 | 3.44 |
| 2026-03-27 | ALC | 73.34 | 13.2 | 61.3 | 3.44 |
| 2026-03-30 | ALC | 73.70 | 13.2 | 86.7 | 3.44 |
| 2026-03-31 | ALC | 75.32 | 13.2 | 108.9 | 3.44 |
| 2026-04-01 | ALC | 75.52 | 13.2 | 119.4 | 3.44 |
| 2026-04-02 | ALC | 74.59 | 13.2 | 99.0 | 3.44 |
| 2026-04-06 | ALC | 74.66 | 13.2 | 113.8 | 3.44 |
| 2026-04-07 | ALC | 74.68 | 13.2 | 112.4 | 3.44 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-03-09 | ALC | 0.00 | -0.31 | 1.34 |
| 2026-03-10 | ALC | 0.00 | -0.31 | 1.34 |
| 2026-03-11 | ALC | 0.00 | -0.31 | 1.10 |
| 2026-03-12 | ALC | 0.00 | -0.31 | 1.10 |
| 2026-03-13 | ALC | 0.00 | -0.31 | 1.10 |
| 2026-03-17 | ALC | 0.00 | -0.80 | 1.10 |
| 2026-03-18 | ALC | 0.00 | -0.80 | 1.10 |
| 2026-03-19 | ALC | 0.00 | -0.80 | 1.10 |
| 2026-03-20 | ALC | 0.00 | -0.80 | 1.10 |
| 2026-03-23 | ALC | 0.00 | -0.77 | 1.10 |
| 2026-03-24 | ALC | 0.00 | -0.77 | 1.10 |
| 2026-03-25 | ALC | 0.00 | -0.77 | 1.00 |
| 2026-03-26 | ALC | 0.00 | -0.77 | 1.00 |
| 2026-03-27 | ALC | 0.00 | -0.77 | 1.00 |
| 2026-03-30 | ALC | 0.00 | -0.76 | 1.00 |
| 2026-03-31 | ALC | 0.00 | -0.76 | 1.00 |
| 2026-04-01 | ALC | 0.00 | -0.76 | 1.00 |
| 2026-04-02 | ALC | 0.00 | -0.76 | 1.00 |
| 2026-04-06 | ALC | 0.00 | -0.42 | 1.00 |
| 2026-04-07 | ALC | 0.00 | -0.42 | 1.00 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
0.78
Avg. EPS Est. Current Quarter
0.83
Avg. EPS Est. Next Quarter
0.49
Insider Transactions
Institutional Transactions
-0.42
Beta
1.02
Average Sales Estimate Current Quarter
2720
Average Sales Estimate Next Quarter
2787
Fair Value
80.33
Quality Score
85
Growth Score
77
Sentiment Score
81
Actual DrawDown %
26.1
Max Drawdown 5-Year %
-35.9
Target Price
96.9
P/E
37.81
Forward P/E
19.03
PEG
1.44
P/S
3.5
P/B
1.65
P/Free Cash Flow
21.06
EPS
1.97
Average EPS Est. Cur. Y
3.44
EPS Next Y. (Est.)
2.8
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
9.42
Relative Volume
0.87
Return on Equity vs Sector %
-23
Return on Equity vs Industry %
-5.1
EPS 1 7Days Diff
EPS 1 30Days Diff
0.01
EBIT Estimation
112.4
◆
ALC
Healthcare
$74.67
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
39.6
Range 1M
17.1%
Sup Dist
0.7%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
11.8%
EPS NY
14.3%
52W%
11.5%
Long-Term Value
Quality companies, undervalued
WEAK
🔴 SELL
-0.5% upside
Upside
-0.5%
Quality
85
MoS
8%
Alcon Inc.Sector: Healthcare
Industry: Medical Instruments & Supplies
Employees: 25942
Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. The company's cataract products include Unity CS, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS biometer, SMARTCATARACT health platform, NGENUITY 3D visualization system, LuxOR surgical ophthalmic microscope, and ORA system for intra-operative measurements; ADI cloud-based platform; and implantable products, including monofocal, Toric, and Presbyopia-Correcting IOLs, as well as delivery systems, such as AutonoMe and UltraSert. In addition, it provides Custom Pak surgical procedure packs vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, Grieshaber, MIVS instruments; scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit probes; and refractive surgery products, including WaveLight and Contoura Vision used for LASIK refractive procedure. Further, the company offers daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.
ALC
Latest News
—
Caricamento notizie per ALC…
stock quote shares ALC – Alcon Inc. Stock Price stock today
news today ALC – Alcon Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch ALC – Alcon Inc. yahoo finance google finance
stock history ALC – Alcon Inc. invest stock market
stock prices ALC premarket after hours
ticker ALC fair value insiders trading